Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

AAM. 2022; 11(2): 135-144


The Effect of Rasanjanadi Taila Nasya and Gudardraka internally in Vataja Pratishyaya ( Allergic Rhinitis ): A Randomized Comparative Clinical Study

Vaishali Jotiram Pawar, Pradeep Kumar K..




Abstract

In Pratishyaya (Rhinitis), Vata is the main Dosha (humors) associated with Kapha, Pitta and Rakta (Blood) in its manifestation. Its improper management leads to Dushta Pratishyaya and further may cause complications like Badhirya (Hearing loss), Andhatwa (Blindness), Aghranatwam (Anosmia). Vataja Pratishyaya may be correlated with Allergic Rhinitis which is the commonest disease affecting more than 30% to 40% of all allergies in India. This study is aimed to understand the efficacy of Rasanjanadi Taila Nasya (Instillation of medicated oil in nostrils) and Gudardraka internally in Vataja Partishaya (Allergic Rhinitis). A randomized comparative clinical study of three groups (15 patients in each) was carried where patients in Group-A were given with Gudardraka orally, Group-B were given with Rasanjanadi Taila Nasya and in Group-C were given Rasanjanadi Taila Nasya along with Gudardraka orally. Assessment was done on the basis of subjective and objective parameters and analysed by Pearson’s Chi-square test. Objective parameters, within the group was analysed with paired t-test and between groups Repeated Measure ANOVA test. Intra-group comparison showed statistically significant results in all three Groups with a steady decrease in symptoms. The comparative analysis showed Group-C was the most effective with 53.3 % cure rate and remaining 46.6 % patients with marked relief.

Key words: Vajata Pratishyaya, Rasanjanadi Taila, Gudardraka, Nasya, Allergic Rhinitis.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.